Following a US FDA warning over a rare vision-loss condition, specialists say the absolute risk remains low, while the metabolic and cardiovascular benefits of GLP-1 drugs are substantial
Following a US FDA warning over a rare vision-loss condition, specialists say the absolute risk remains low, while the metabolic and cardiovascular benefits of GLP-1 drugs are substantial
<iframe src="https://hindustansphere.com/embed/cluster/9012528308c39525207196aeac7cd1ff5352ceb8" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Doctors caution against stopping weight-loss drugs over vision-loss risk"></iframe>
